Previous Article | Next Article ![]()
Journal of Bacteriology, April 2001, p. 2376-2379, Vol. 183, No. 7
Department of Molecular Biosciences, Adelaide
University, South Australia 5005, Australia
Received 8 June 2000/Accepted 10 January 2001
A single-copy chromosomal reporter system was used to measure the
intrinsic strengths and interactions between the three promoters involved in the establishment of lysogeny by coliphage 186. The maintenance lysogenic promoter pL for the
immunity repressor gene cI is intrinsically ~20-fold
weaker than the lytic promoter pR. These
promoters are arranged face-to-face, and transcription from pL is further weakened some 14-fold by the
activity of pR. Efficient establishment of
lysogeny requires the pE promoter, which lies upstream of pL and is activated by the phage
CII protein to a level comparable to that of
pR. Transcription of pE
is less sensitive to converging pR
transcription and raises cI transcription at least 55-fold.
The pE promoter does not occlude
pL but inhibits lytic transcription by 50%.
This interference is not due to bound CII preventing elongation of the
lytic transcript. The pE RNA is antisense to
the anti-immune repressor gene apl, but any role of this in
the establishment of lysogeny appears to be minimal.
Temperate bacteriophages provide
model systems for studying developmental switches. One question of
interest is how these phages achieve efficient and conditional
transitions between the lytic and lysogenic alternative developmental
states. Bacteriophage lambda, in response to DNA-damaging agents,
leaves the lysogenic state and enters lytic development, a process
termed prophage induction (7). The reverse transition,
establishment of lysogeny, is conditional in lambda upon the activity
of a lytic operon gene, cII (9), that responds
to the physiology of the infected cell (24). Bacteriophage
P2 is the prototype of the second major group of temperate
bacteriophages of Escherichia coli (2, 3), and
its genome shares very little DNA homology with lambda
(4). P2 forms a noninducible prophage and does not require
a cII-like gene in order to establish lysogeny
(4). However, these traits are not shared by all P2-like
phages. Bacteriophage 186 is highly related to P2 (4) yet
is like lambda in being SOS inducible (28) and requiring a
cII gene for efficient lysogenization (11).
Lytic and lysogenic development are controlled in these phages by a
stable switch formed by the lytic and lysogenic promoters and the first
genes of the divergent lytic and lysogenic operons (Fig.
1). In lysogeny, the lysogenic or
maintenance promoter
(pRM/pL/pc) is active, resulting in production of the immunity repressor (CI/C), which represses the lytic promoter
(pR/pe) and stimulates
the lysogenic promoter. Prophage induction in lambda and 186 involves inactivation of the CI protein by activated RecA coprotease
(17) or by a phage-encoded protein, Tum (10).
In lytic development, the lytic promoter is active and the first gene
of the lytic transcript encodes a repressor (Cro/Apl/Cox) that
modulates the activity of the switch promoters (12, 15,
19). Initially, upon lytic infection of a sensitive cell, no
immunity repressor is present. Establishment of lysogeny requires that
adequate immunity repressor is made sufficiently quickly to block lytic
development. Once present, the immunity repressor stimulates the
lysogenic promoter and maintains its own production. In lambda and 186, but not P2, establishment of lysogeny requires an alternative promoter
for cI
(pRE/pE) that lies distal
to the cro and apl genes, respectively (Fig. 1).
This establishment promoter is activated by the binding of CII
(13, 23). The establishment transcript extends antisense across the cro/apl gene, traverses the switch promoters and
the binding sites for the switch proteins, and enters the cI
gene.
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.7.2376-2379.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Establishing Lysogenic Transcription in the Temperate
Coliphage 186

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (27K):
[in a new window]
FIG. 1.
Lysis-lysogeny switches of
, 186, and P2. CI and C
are immunity repressors, and Cro, Apl, and Cox are anti-immunity
repressors. The diagrams are not to scale, but the relative distances
between the repressor and anti-immunity repressor open reading frames
for the three switches are accurate. Note the back-to-back arrangement
of the lytic (pR) and lysogenic
(pRM) promoters in
, their face-to-face
arrangement in 186 (pR and
pL) and P2 (pe and
pc), and the different locations of the binding
sites for the immunity (rectangles) and anti-immunity (filled circles)
repressors. pRE and pE
are the CII-activated establishment promoters of
and 186, respectively.
The activity of lambda pRE appears to promote lysogeny in a number of ways. The pRE promoter is much stronger than pRM (16), and production of CI from the pRE RNA is more efficient than from the pRM transcript, which lacks typical ribosome binding sequences (21). It has also been shown that converging transcription from pRE interferes with lytic transcription from pR (20), and it has been suggested that the pRE RNA might inhibit Cro production by an antisense mechanism (26), although no experiments have tested the latter hypothesis. In this study, we examined the roles of CII and pE in the establishment of lysogeny in 186. We did not expect differences in the efficiency of CI production from the pL and pE transcripts, since they share the 70 bases upstream of the cI start codon; however, we wished to know to what degree CII was able to increase transcription of the cI gene. In addition, we investigated the effect of the apl gene on cI transcription from pL and pE and examined the interactions between these promoters and the pR promoter.
CII increases cI transcription in the face of lytic
transcription.
Given the probability that the lysogenic and
establishment transcripts of cI are equally well translated,
the major reason expected for the involvement of
pE in the establishment of lysogeny in 186 was
the enhanced transcription of cI in the face of converging transcription from the lytic promoter, which has previously been shown
to reduce the activity of pL (5).
In order to compare the strengths of these promoters, lacZ
fusions were constructed and single copies of each were inserted into
the bacterial chromosome, using the system of Simons et al.
(25). To avoid the potential influence of sequence context
on the promoter assay, all the comparative studies involved the same
restriction fragment, carrying the three promoters under study but
bearing mutations inactivating different promoters as appropriate. To
inactivate the lytic promoter pR, the
35
sequence was altered from TTTACT to CTCGAG
(15), whereas to inactivate the lysogenic promoter,
pL the
10 sequence was altered from
TAGATT to GCGCTT. The absence of active CII
essentially inactivated the establishment promoter. The
-galactosidase activities obtained represent transcription across
the control region and approximately the first 500 bp of the immunity
repressor gene.
PN78) increased 86-fold, from 6 to 517 U, while converging
transcription from pR (
PN117) was reduced
1.7-fold, from 1,278 to 760 U (Fig. 2).
This effect of CII represented a 145-fold shift in the relative strengths of cI transcription and lytic transcription.
|
Apl has little or no effect on the establishment of transcription
of the immunity repressor gene.
The Apl protein binds to a series
of seven direct repeats that overlap the transcription start points of
the lytic and lysogenic transcripts (6)(Fig. 1).
Initial studies suggested an inhibitory role on transcription
from pL for Apl
(anti-pL)(5). Subsequently, Reed et
al. (15) suggested that pR
activity was more sensitive than pL to Apl and
that the absence of Apl had little impact on the frequency with which
infections followed the lytic or lysogenic pathway of infection
(6). In the present study, we showed (Fig. 2) that Apl
expressed from the single-copy reporter construct was sufficient to
repress the lytic promoter twofold, from 2,275 U (
PN332) to 1,278 U
(
PN117), and that Apl appeared to act in concert with CII in
reducing overall lytic transcription to 760 U (
PN117). However,
despite this reduction in converging transcription, the presence of Apl
made little improvement in leftward transcription, which increased from
444 U (
PN157) to 517 U (
PN78), which is within the 90%
confidence limits; Apl also presented no barrier to the passage of RNA
polymerase from pE. These facts are in
accordance with the demonstration by Dodd et al. (6) that
Apl had no role in the lysis-lysogeny decision.
Promoter interactions. (i) pE and
pL activities are additive.
The strength
of pL alone measured 115 U (
PN538) and the
base changes made at pL reduced this activity to
2 U (
PN610), essentially inactivating it (Fig. 2). The strength of
pE in the absence of pL
was 1,447 U (
PN610), 13-fold greater than that of
pL. The sum of the individual promoter strengths
(1,562 U) is similar to their combined measurement of 1,625 U
(
PN538), indicating that the two transcripts neither
interfered with nor assisted one another but rather were simply additive.
(ii) cI transcription in the face of
pR activity.
In the presence of
pR, lysogenic transcription was reduced 14-fold,
from 115 U (
PN538) to 8 U (
PN157), while transcription from
pE was reduced twofold, from 1,447 U (
PN610)
to 696 U (
PN612). Given the additivity of transcription from
pE and pL observed in the
absence of pR, the expectation was that leftward
transcription in the face of converging transcription from
pR would also be greater for the combined
activities of pE and pL
than that found in the presence of pE alone. It
was therefore surprising that leftward transcription fell from 696 U in
the absence of pL (
PN612) to 444 U when
pL was present (
PN157). It appeared as if the
association of RNA polymerase with pL sensitized
transcription from pE to interference by
transcription from pR.
(iii) pE interference with
pR activity.
Transcription from
pE reduced transcription from
pR by 801 U, from 2,275 to 1,474 U (
PN332).
Some of the interference of pE on
pR could arise from CII bound at
pE acting as a roadblock to the rightward
movement of RNA polymerase from pR. To test this possibility, we used the KS11 mutant of pE
(22) in which a T-to-C base-pair change in the
10 region
eliminates activity of pE (<0.1% of wild type)
without altering the DNA binding affinity of CII. In this experiment
(Fig. 3), wild-type
pE activity caused a 25% reduction in
pR activity (618 to 462 U), whereas no reduction was seen with the KS11 mutant. Thus, inhibition of
pR by pE is not due to
CII blocking the progress of RNA polymerase but requires pE activity.
|
Conclusions.
We have shown that the transcription factor CII
elevates 86-fold the transcription of the immunity repressor gene in
the face of converging transcription from the lytic promoter, although we have as yet no evidence for the physiological relevance of the CII
concentration generated in the present experiments. Furthermore, the
elevation of the lysogenic transcription from pL
from 8 to 115 U, when the converging transcription from
pR is eliminated by mutation, confirms the
proposition (5) that repression of the lytic promoter by
the immunity repressor would lead to enhanced transcription of the
immunity repressor gene. This suggestion not only provides a mechanism
for positive feedback in the expression of the immunity repressor but
also is consistent with a transient requirement for CII in the
establishment of lysogeny. Thus, despite the fundamental difference in
switch promoter arrangement, the role of CII in establishing the
conditions for positive autoregulation of the immunity repressor is, in
principle, the same for 186 and
. A potential advantage to
lysogenization, attributed to the action of the CII-activated
transcription from pRE after
infection (20), is the reduction of lytic transcription from the
convergent lytic promoter pR, with the
consequent reduction in the synthesis of the anti-immune repressor Cro.
In 186, reduced lytic transcription was seen in the presence of active
pE, but this proved of no obvious advantage to
transcription from the lysogenic promoter pL. In addition, the presence of Apl displayed little impact on the level of
cI transcription, so that any reduction in Apl synthesis
associated with reduced lytic transcription would be of little consequence.
(7) from P2 (2), and the potential interrelationship of prophage
inducibility and the CII requirement will be explored in future studies.
Our final comments concern the 14-fold reduction of lysogenic promoter
activity in the presence of an active lytic promoter. The lysogenic
promoters of both P2 (19) and lambda (8) are also inhibited by the activities of their respective lytic promoters. The transcription start points of the lytic and lysogenic promoters are
separated by 62 bp in 186 (5) and by 82 bp in lambda
(8). In the case of P2, we predict from the sites of the
presumptive
10 regions (18) about a 40-bp separation. As
the switch promoters of lambda are arranged back-to-back and the RNA
polymerase DNase I footprint overlaps +20 to
55 of an E. coli promoter (14), the possibility of RNA polymerase
bound at one promoter precluding an RNA polymerase from binding at the
second promoter was real, but the interference appears to occur at the
open complex formation rather than at the binding step
(8). For the face-to-face arrangement of switch promoters
of 186 and P2, the probability is that RNA polymerases can occupy both
promoters simultaneously. The nature of the interference for these
phages has yet to be determined but presumably involves some step
subsequent to the binding of the RNA polymerase to the promoter. If
interference is due to an elongating RNA polymerase from the lytic
promoter dislodging an RNA polymerase slow to clear the lysogenic
promoter, then directionality may be important, for we did not find
promoter occlusion (1) of pL by
transcription from the upstream promoter pE. The
nature of promoter interference is currently under study in this laboratory.
| |
ACKNOWLEDGMENTS |
|---|
We thank Ian Dodd and Benji Callen for critical contributions.
This work was supported by a grant from the Australian Research Council to J. Barry Egan, an ARC fellowship to Keith E. Shearwin, and an Adelaide University postgraduate scholarship to Petra J. Neufing.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Biosciences, Adelaide University, South Australia 5005, Australia. Phone: 61 8 8303 5361. Fax: 61 8 8303 4348. E-mail: barry.egan{at}adelaide.edu.au.
Present address: School of Medicine, Flinders Medical Centre,
Flinders University, Bedford Park, South Australia 5042, Australia.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Adhya, S., and M. Gottesman. 1982. Promoter occlusion: transcription through a promoter may inhibit its activity. Cell 29:939-944[CrossRef][Medline]. |
| 2. | Bertani, L. E., and G. Bertani. 1971. Genetics of P2 and related phages. Adv. Genet. 16:199-237[Medline]. |
| 3. |
Dhillon, E. K. S.,
T. S. Dhillon,
Y. Y. Lam, and A. H. C. Tsang.
1980.
Temperate coliphages: classification and correlation with habitats.
Appl. Environ. Microbiol.
39:1046-1053 |
| 4. | Dodd, I. B., and J. B. Egan. 1999. P2, 186 and related phages (Myoviridae), p. 1087-1094. In R. G. Webster, and A. Granoff (ed.), Encyclopaedia of virology, 2nd ed. Academic Press, London, United Kingdom. |
| 5. | Dodd, I. B., B. Kalionis, and J. B. Egan. 1990. Control of gene expression in the temperate coliphage 186. VIII. Control of lysis and lysogeny by a transcriptional switch involving face-to-face promoters. J. Mol. Biol. 214:27-37[CrossRef][Medline]. |
| 6. | Dodd, I. B., M. R. Reed, and J. B. Egan. 1993. The Cro-like repressor of coliphage 186 is required for prophage excision and binds near the phage attachment site. Mol. Microbiol. 10:1139-1150[CrossRef][Medline]. |
| 7. | Goldthwait, D., and F. Jacob. 1964. Sur le mécanisme de l'induction du développement du prophage chez les bactéries lysogènes. C. R. Acad. Sci. 259:661-664. |
| 8. |
Hershberger, P. A., and P. L. de Haseth.
1991.
RNA polymerase bound to the pR promoter of bacteriophage inhibits open complex formation at the divergently transcribed PRM promoter.
J. Mol. Biol.
222:479-494[CrossRef][Medline].
|
| 9. | Kaiser, A. D. 1957. Mutations in a temperate bacteriophage affecting its ability to lysogenize Escherichia coli. Virology 3:42-61[CrossRef][Medline]. |
| 10. |
Lamont, I.,
A. M. Brumby, and J. B. Egan.
1989.
UV induction of coliphage 186: prophage induction as an SOS function.
Proc. Natl. Acad. Sci. USA
86:5492-5496 |
| 11. |
Lamont, I.,
H. Richardson,
D. R. Carter, and J. B. Egan.
1993.
Genes for the establishment and maintenance of lysogeny by the temperate coliphage 186.
J. Bacteriol.
175:5286-5288 |
| 12. | Meyer, B. J., R. Maurer, and M. Ptashne. 1980. Gene regulation at the right operator (oR) of bacteriophage lambda. II. oR1, oR2, and oR3: their roles in mediating the effects of repressor and Cro. J. Mol. Biol. 139:163-194[CrossRef][Medline]. |
| 13. | Neufing, P. J., K. E. Shearwin, J. Camerotto, and J. B. Egan. 1996. The CII protein of bacteriophage 186 establishes lysogeny by activating a promoter upstream of the lysogenic promoter. Mol. Microbiol. 21:751-761[CrossRef][Medline]. |
| 14. |
Record, M. T., Jr.,
W. S. Reznikoff,
M. L. Craig,
K. L. McQuade, and P. J. Schlax.
1996.
Escherichia coli RNA polymerase (E 70), promoters, and the kinetics of the steps of transcription initiation, p. 792-821.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella, 2nd ed., vol. 1. ASM Press, Washington, D.C.
|
| 15. | Reed, M. R., K. E. Shearwin, and J. B. Egan. 1997. The dual role of the Cro-like Apl protein in prophage induction of coliphage 186. Mol. Microbiol. 23:669-681[CrossRef][Medline]. |
| 16. |
Reichardt, L. F., and A. D. Kaiser.
1971.
Control of lambda repressor synthesis.
Proc. Natl. Acad. Sci. USA
68:2185-2189 |
| 17. |
Roberts, J. W.,
C. W. Roberts, and N. L. Craig.
1978.
Escherichia coli recA gene product inactivates phage lambda repressor.
Proc. Natl. Acad. Sci. USA
75:4714-4718 |
| 18. | Saha, S., B. Lundqvist, and E. Haggard-Ljungquist. 1987. Autoregulation of bacteriophage P2 repressor. EMBO J. 6:809-814[Medline]. |
| 19. | Saha, S., E. Haggard-Ljungquist, and K. Nordstrom. 1987. The Cox protein of bacteriophage P2 inhibits the formation of the repressor protein and autoregulates the early operon. EMBO J. 6:3191-3199[Medline]. |
| 20. |
Schmeissner, U.,
D. Court,
H. Shimatake, and M. Rosenberg.
1980.
Promoter for the establishment of repressor synthesis in bacteriophage .
Proc. Natl. Acad. Sci. USA
77:3191-3195 |
| 21. |
Shean, C. S., and M. E. Gottesman.
1992.
Translation of the prophage cI transcript.
Cell
70:513-522[CrossRef][Medline].
|
| 22. |
Shearwin, K. E., and J. B. Egan.
2000.
Establishment of lysogeny in bacteriophage 186. DNA binding and transcriptional activation by the CII protein.
J. Biol. Chem.
275:29113-29122 |
| 23. |
Shimatake, H., and M. Rosenberg.
1981.
Purified regulatory protein CII positively activates promoters for lysogenic development.
Nature
292:128-132[CrossRef][Medline].
|
| 24. |
Shotland, Y.,
A. Shifrin,
T. Ziv,
D. Teff,
S. Koby,
O. Kobiler, and A. B. Oppenheim.
2000.
Proteolysis of bacteriophage CII by Escherichia coli FtsH (HflB).
J. Bacteriol.
182:3111-3116 |
| 25. | Simons, R. W., F. Houman, and N. Kleckner. 1987. Improved single and multicopy lac based cloning vectors for protein and operon fusions. Gene 53:85-96[CrossRef][Medline]. |
| 26. |
Spiegelman, W. G.,
L. F. Reichardt,
M. Yaniv,
S. F. Heinemann,
A. D. Kaiser, and H. Eisen.
1972.
Bidirectional transcription and the regulation of phage repressor synthesis.
Proc. Natl. Acad. Sci. USA
69:3156-3160 |
| 27. | Wilks, S. S. 1948. Elementary statistical analysis. Princeton University Press, Princeton, N.J. |
| 28. |
Woods, W. H., and J. B. Egan.
1974.
Prophage induction of noninducible coliphage 186.
J. Virol.
14:1349-1356 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |